Furthermore, the company noted that the Reuters reporter told CNBC and MSNBC during an interview, “There’s no evidence that what [J&J is] selling today has any asbestos in it.”
Despite Johnson &Johnson’s effort defending its Baby Powder, investors remained spooked. JNJ stock was down nearly 3 percent to $129.14 per share today.